What does set Besporea apart?
What does set Besporea apart?
In addition to our expertise in the UK research landscape, Besporea stands out for its deep understanding of site-level processes and needs—including capacity and capabilities, resource allocation, realistic timelines, budgets, contracts, and communication preferences. These factors are often the primary causes of study start-up delays, far more so than regulatory or ethics approvals.
Sponsors and CROs may overlook these critical aspects or lack direct site-level experience. Besporea bridges this gap, providing unmatched site-specific expertise alongside other study start-up components. By addressing these challenges head-on, we enable faster, smoother trial start-up and efficient delivery, helping you achieve your research goals without compromise.
As we grow and evolve, our commitment to excellence and patient-centric research remains at the heart of everything we do.
Our Value Services and Solutions
Phase I – IV & real-world evidence studies start-up services
Feasibility studies and site selection
Budget and contract negotiation
Ethics & regulatory submissions
Amendments
Vendors and sites management
Site readiness and activation
Project management and clinical operations
Bespoke consulting
Public health
Research transition & homecare planning
Training and upskilling
Strategy consulting
Emerging trends such as decentralised clinical trials & platform trials.
Paediatrics and adults
Rare diseases: CLN2, MPS, Epidermolysis Bullosa, Pulmonary Hypertension, & more.
Emerging technologies: mRNA and Cell and Gene Therapy.
Diverse therapeutic areas: Metabolic, Gastroenterology, Haematology, Dermatology, Infectious Diseases & more.